SCHEMBL948108

SCHEMBL948108

CCCCCCCCCCSCCNCCSCCCCCCCCCC

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.50
ALDH1A1 P00352 1/20 0.50
CES2 O00748 3/20 0.45
THRB P10828 2/20 0.45
GMNN O75496 1/20 0.45
TP53 P04637 1/20 0.45
POLB P06746 1/20 0.45
MAPT P10636 1/20 0.45
CYP2C9 P11712 1/20 0.45
BLM P54132 1/20 0.45
HSD17B10 Q99714 1/20 0.45
CA2 P00918 1/20 0.43
EPHX1 P07099 2/20 0.41
ADH1B P00325 1/20 0.41
ADH1C P00326 1/20 0.41
ADH1A P07327 1/20 0.41
ADH4 P08319 1/20 0.41
ADH7 P40394 1/20 0.41
FAAH O00519 4/20 0.39
CES1 P23141 4/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31357726 1.00 TSHR (0.50) TSHRALDH1A1CES2THRBGMNN
SCHEMBL19627041 1.00 TSHR (0.50) TSHRALDH1A1CES2THRBGMNN
SCHEMBL7483245 1.00 TSHR (0.50) TSHRALDH1A1CES2THRBGMNN
Hydrochloric Acid SCHEMBL31575716 0.95 TSHR (0.46) TSHRALDH1A1CES2THRBGMNN
SCHEMBL10766453 0.91 TSHR (0.50) TSHRALDH1A1CES2THRBGMNN
SCHEMBL947082 0.90 TSHR (0.48) TSHRALDH1A1CES2THRBGMNN
SCHEMBL9426392 0.89 CES2 (0.42) TSHRALDH1A1CES2THRBGMNN
SCHEMBL8023801 0.89 CES2 (0.42) TSHRALDH1A1CES2THRBGMNN
SCHEMBL9679800 0.88 TSHR (0.62) TSHRALDH1A1EPHX1ADH1BADH1C
SCHEMBL20714591 0.88 FAAH (0.50) GMNNPOLBMAPTCYP2C9BLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1456152-B1 TRIMERISATION AND OLIGOMERISATION OF OLEFINS USING A CHROMIUM BASED CATALYST SASOL TECH PTY LTD (ZA) 2012-06-13 EP claimed
JP-4308015-B2 2009-08-05 JP claimed
US-7300904-B2 Trimerisation and oligomerisation of olefins using a chromium based catalyst SASOL TECHNOLOGY (PTY) LTD. (ZA) 2007-11-27 US claimed
JP-2005533872-A 2005-11-10 JP claimed
US-20050131262-A1 Trimerisation and oligomerisation of olefins using a chromium based catalyst SASOL TECHNOLOGY (PTY) LTD. (ZA) 2005-06-16 US claimed
EP-1456152-A1 TRIMERISATION AND OLIGOMERISATION OF OLEFINS USING A CHROMIUM BASED CATALYST Sasol Technology (Pty) Ltd (ZA) 2004-09-15 EP claimed
WO-2003053890-A1 TRIMERISATION AND OLIGOMERISATION OF OLEFINS USING A CHROMIUM BASED CATALYST SASOL TECHNOLOGY (PTY) LTD (ZA) 2003-07-03 WO claimed
EP-2287144-B1 Methods of preparation of an olefin oligomerization catalyst CHEVRON PHILLIPS CHEMICAL CO LP (US) 2018-04-11 EP disclosed
EP-2287143-B1 Methods of preparation of an olefin oligomerization catalyst CHEVRON PHILLIPS CHEMICAL CO LP (US) 2018-04-11 EP disclosed
US-20170044275-A9 Methods of Preparation of an Olefin Oligomerization Catalyst CHEVRON PHILLIPS CHEMICAL COMPANY LP 2017-02-16 US disclosed
US-9550841-B2 Methods of preparation of an olefin oligomerization catalyst CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2017-01-24 US disclosed
US-20160251455-A1 Methods of Preparation of an Olefin Oligomerization Catalyst CHEVRON PHILLIPS CHEMICAL CO LP (US) 2016-09-01 US disclosed
EP-1716089-B1 METHODS OF PREPARATION OF AN OLEFIN OLIGOMERIZATION CATALYST CHEVRON PHILLIPS CHEMICAL CO (US) 2015-04-08 EP disclosed
EP-1716089-A1 METHODS OF PREPARATION OF AN OLEFIN OLIGOMERIZATION CATALYST Chevron Phillips Chemical Company LP (US) 2006-11-02 EP disclosed
WO-2005082816-A1 METHODS OF PREPARATION OF AN OLEFIN OLIGOMERIZATION CATALYST CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2005-09-09 WO disclosed
US-20050187391-A1 Methods of preparation of an olefin oligomerization catalyst CHEVRON PHILLIPS CHEMICAL COMPANY LP 2005-08-25 US disclosed
US-20050187098-A1 Methods of preparation of an olefin oligomerization catalyst CHEVRON PHILLIPS CHEMICAL COMPANY, LP 2005-08-25 US disclosed
US-20050131262-A1 Trimerisation and oligomerisation of olefins using a chromium based catalyst SASOL TECHNOLOGY (PTY) LTD. (ZA) 2005-06-16 US disclosed
EP-1456152-A1 TRIMERISATION AND OLIGOMERISATION OF OLEFINS USING A CHROMIUM BASED CATALYST Sasol Technology (Pty) Ltd (ZA) 2004-09-15 EP disclosed
WO-2003053890-A1 TRIMERISATION AND OLIGOMERISATION OF OLEFINS USING A CHROMIUM BASED CATALYST SASOL TECHNOLOGY (PTY) LTD (ZA) 2003-07-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050187391-A1 Methods of preparation of an olefin oligomerization catalyst ZRANB2, COG4, PPOX TSHR 3138/4885ALDH1A1 4742/4885CES2 3901/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.